Furthermore, a tumor suppressive gene, DAB2IP, reported by Wang et al. suggests that DAB2IP CpG1 methylation is a practical and repeatable biomarker for ccRCC, which can provide prognostic value that complements the current staging system. This evidence concerns the gene DAB2IP and neoplasm.